Literature DB >> 11186935

Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2).

D G Evans, V Newton, W Neary, M E Baser, A Wallace, R Macleod, J P Jenkins, J Gillespie, R T Ramsden.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11186935      PMCID： PMC1734490          DOI： 10.1136/jmg.37.12.944

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  5 in total

Review 1.  Neurofibromatosis type 2.

Authors:  D G Evans; M Sainio; M E Baser
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

2.  Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.

Authors:  Nicolas -Xavier Bonne; Rabih Aboukais; Marc Baroncini; Audrey Hochart; Pierre Leblond; Franck Broly; Frédérique Dubrulle; Jean-Paul Lejeune; Christophe Vincent
Journal:  Childs Nerv Syst       Date:  2016-10-04       Impact factor: 1.475

Review 3.  Neurofibromatosis type 2 (NF2): a clinical and molecular review.

Authors:  D Gareth R Evans
Journal:  Orphanet J Rare Dis       Date:  2009-06-19       Impact factor: 4.123

Review 4.  The role of the Hippo pathway in human disease and tumorigenesis.

Authors:  Daniel A Barron; Jacob D Kagey
Journal:  Clin Transl Med       Date:  2014-07-18

5.  Atypical teratoid rhabdoid tumor mimicking type II neurofibromatosis: A case report.

Authors:  Zhipeng Shen; Ning Wang; Wujie Shi; Peiliang Zhang; Jianbin Weng; Hanhai Zeng
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.